BI
GILD icon

Binnacle Investments’s Gilead Sciences GILD Stock Holding History

Binnacle Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$87.1K Buy
785
+83
+12% +$9.43K 0.05% 119
2025
Q2 		$77.8K Buy
702
+88
+14% +$9.37K 0.05% 116
2025
Q1 		$68.8K Buy
+614
New +$63.4K 0.05% 115

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Binnacle Investments's GILD Position: Q3 2025 in Review

Binnacle Investments increased its Gilead Sciences (GILD) stake by 12% in Q3 2025, buying an estimated $9.43K and bringing the position to 785 shares worth $87.1K. The position accounts for 0.05% of the portfolio, ranked #119.

Binnacle Investments first reported a position in GILD in Q1 2025 and has held it in 3 quarters since. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Binnacle Investments held 785 shares of Gilead Sciences worth $87.1K as of Q3 2025.
  • Binnacle Investments bought 83 Gilead Sciences shares in Q3 2025, an estimated $9.43K.
  • Gilead Sciences made up 0.05% of Binnacle Investments's portfolio in Q3 2025, its #119 holding.
  • Binnacle Investments first reported a position in Gilead Sciences in Q1 2025 and has held it in 3 quarters since.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.